BACTERIAL AND VIRAL SPECIMEN COLLECTION MARKET ANALYSIS

Key Developments

• On June 4, 2024, a study published in The Lancet and by the European Health Union highlighted Dutch scientist Rochelle Niemeijer’s development of an affordable, AI-driven tool for diagnosing bacterial infections. Niemeijer is a finalist for the Young Inventors Prize, competing against teams from Tunisia and Ukraine, for her work advancing one of the UN’s Sustainable Development Goals
• On January 19, 2024, ELITechGroup launched the ‘GI Bacterial PLUS ELITe MGB Kit,’ an in-vitro diagnostic tool for detecting key gastrointestinal bacterial pathogens, including Yersinia enterocolitica, Clostridium difficile, Shigella species, Campylobacter species, and Salmonella species.
• In December 2023, HiMedia Laboratories Private Limited, a bioscience firm, announced that it had received approval from the Central Drugs Standard Control Organization (CDSCO) to import the NG-Test CARBA 5 kit from NG Biotech, a biotechnology company based in France.
• In January 2022, BD (Becton, Dickinson and Company) and Pfizer Inc. announced a collaboration to explore the role of diagnostics in enhancing antimicrobial stewardship globally. This partnership will assess current diagnostic practices to identify both benefits and gaps in antimicrobial resistance (AMR) stewardship. The aim is to improve patient care, clinical practices, and health care economics by advancing the role of diagnostics in combating AMR.